Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PANW +12.4%, RMAX +1.5% (guidance; workforce reduction)
Other news:
- BIVI +34.9% (files $300 mln mixed shelf securities offering; also files for 311002 shares common stock by selling shareholders)
- GFGD +24.3% (ZeroNox & GFGD PIPE financing to support long-term growth strategy)
- ESTE +8.4% (Permian Resources (PR) to acquire Earthstone Energy in all-stock transaction)
- VMW +6.5% (UK CMA clears Broadcom's (AVGO) deal to buy Vmware)
- CALT +6.1% (Everest Medicines announces partner Calliditas Therapeutics receives FDA Priority Review for full approval of Nefecon)
- CABO +5% (increase its quarterly dividend 3.5% to $2.95/share)
- ZS +4.7% (in sympathy with PANW earnings)
- KRYS +4.7% (completed the sale of its Rare Pediatric Disease Priority Review Voucher for $100 mln)
- AXGN +4% (announces the successful first week of processing for Avance Nerve Graft at the newly opened Axogen Processing Center in Dayton Ohio)
- CRWD +3.3% (in sympathy with PANW earnings)
- SCU +2.7% (issues statement regarding receipt of unsolicited insufficiently funded proposal)
- TTE +2.6% (acquires a 26% interest in the Cash-Maple Gas Discoveries for the long-term supply of Ichthys LNG)
- EQNR +2.6% (announced on 4 May 2023 an ordinary dividend of $0.30/share (unchanged) and an extraordinary dividend of $0.60/share for Q1)
- NVDA +2.5% (positive Barron's ariticle)
- KVUE +2.1% (Johnson & Johnson (JNJ) announces preliminary results of KVUE exchange offer)
- CYBR +2% (in sympathy with PANW earnings)
- FTNT +1.9% (in sympathy with PANW earnings)
- APGE +1.9% (appoints Mark McKenna as Chairman)
Analyst comments:
- XPEV +5.3% (upgraded to Buy from Neutral at BofA Securities)
- GOLF +2.7% (upgraded to Buy from Hold at Jefferies)
- APPF +1.7% (upgraded to Overweight from Equal-Weight at Stephens)
- CCOI +1% (upgraded to Neutral from Sell at Goldman)